2.1(top 20%)
impact factor
2.8K(top 10%)
papers
50.2K(top 5%)
citations
78(top 10%)
h-index
2.4(top 20%)
extended IF
3.5K
all documents
53.5K
doc citations
107(top 10%)
g-index

Top Articles

#TitleJournalYearCitations
1Epidemiology and outcome of invasive fungal infections in solid organ transplant recipientsTransplant Infectious Disease2010390
2The incidence of invasive aspergillosis among solid organ transplant recipients and implications for prophylaxis in lung transplantsTransplant Infectious Disease2002338
3Emerging fungal pathogens: evolving challenges to immunocompromised patients for the twenty-first centuryTransplant Infectious Disease1999257
4Identifying the patient at risk for post‐transplant lymphoproliferative disorderTransplant Infectious Disease2001234
5European guidelines for diagnosis and treatment of adenovirus infection in leukemia and stem cell transplantation: summary of ECIL‐4 (2011)Transplant Infectious Disease2012234
6Outcome of treatment of Epstein–Barr virus‐related post‐transplant lymphoproliferative disorder in hematopoietic stem cell recipients: a comprehensive review of reported casesTransplant Infectious Disease2009196
7Pre-transplant cytomegalovirus (CMV) serostatus remains the most important determinant of CMV reactivation after allogeneic hematopoietic stem cell transplantation in the era of surveillance and preemptive therapyTransplant Infectious Disease2010161
8Ex vivo monitoring of human cytomegalovirus-specific CD8+ T-cell responses using QuantiFERON�-CMVTransplant Infectious Disease2007155
9Epstein-Barr virus load monitoring: its role in the prevention and management of post-transplant lymphoproliferative diseaseTransplant Infectious Disease2001151
10Pre‐ and post‐engraftment bloodstream infection rates and associated mortality in allogeneic hematopoietic stem cell transplant recipientsTransplant Infectious Disease2005149
11Acute graft pyelonephritis following renal transplantationTransplant Infectious Disease2006147
12Bacterial urinary tract infection after solid organ transplantation in the RESITRA cohortTransplant Infectious Disease2012146
13Histoplasmosis in solid organ transplant recipients at a large Midwestern university transplant centerTransplant Infectious Disease2005140
14Infection with Klebsiella pneumoniae carbapenemase (KPC)‐producing K. pneumoniae in solid organ transplantationTransplant Infectious Disease2012140
15The epidemiology and outcomes of invasive Candida infections among organ transplant recipients in the United States: results of the Transplant‐Associated Infection Surveillance Network (TRANSNET)Transplant Infectious Disease2016140
16Mycophenolate mofetil: effects on cellular immune subsets, infectious complications, and antimicrobial activityTransplant Infectious Disease2009139
17Endemic fungal infections in solid organ and hematopoietic cell transplant recipients enrolled in the Transplant‐Associated Infection Surveillance Network (TRANSNET)Transplant Infectious Disease2014138
18Safety and tolerability of caspofungin acetate in the treatment of fungal infectionsTransplant Infectious Disease2002136
19Cryptococcal meningitis: an analysis among 5521 consecutive organ transplant recipientsTransplant Infectious Disease2002129
20Invasive adenoviral infections in T-cell-depleted allogeneic hematopoietic stem cell transplantation: high mortality in the era of cidofovirTransplant Infectious Disease2007129
21The diverse pathology of post-transplant lymphoproliferative disorders: the importance of a standardized approachTransplant Infectious Disease2001128
22Risk factors for Pneumocystis carinii pneumonia in kidney transplant recipients: a case–control studyTransplant Infectious Disease2003125
23Retrospective study of the hepatic safety profile of patients concomitantly treated with caspofungin and cyclosporin ATransplant Infectious Disease2004125
24Infection in solid organ transplantationTransplant Infectious Disease1999124
25Blastomycosis in solid organ transplant recipientsTransplant Infectious Disease2007124
26Infections after T‐replete haploidentical transplantation and high‐dose cyclophosphamide as graft‐versus‐host disease prophylaxisTransplant Infectious Disease2015124
27Etiologic agents of diarrhea in solid organ recipientsTransplant Infectious Disease2007120
28Epidemiology, outcomes, and mortality predictors of invasive mold infections among transplant recipients: a 10‐year, single‐center experienceTransplant Infectious Disease2013120
29Mechanisms of human cytomegalovirus (HCMV) (re)activation and its impact on organ transplant patientsTransplant Infectious Disease1999119
30Infections of the central nervous system in transplant recipientsTransplant Infectious Disease2000119
31Epidemiology of fungal infections in solid organ transplant patientsTransplant Infectious Disease1999118
32Oral maribavir for treatment of refractory or resistant cytomegalovirus infections in transplant recipientsTransplant Infectious Disease2010118
33Multidrug resistant gram‐negative bacilli as predominant bacteremic pathogens in liver transplant recipientsTransplant Infectious Disease2009117
34Possible benefit of intravenous immunoglobulin therapy in a lung transplant recipient with West Nile virus encephalitisTransplant Infectious Disease2002116
35Micafungin alone or in combination with other systemic antifungal therapies in hematopoietic stem cell transplant recipients with invasive aspergillosisTransplant Infectious Disease2009116
36Comparison of conventional and molecular detection of respiratory viruses in hematopoietic cell transplant recipientsTransplant Infectious Disease2009116
37Rapid diagnosis of invasive aspergillosis by antigen detectionTransplant Infectious Disease2003115
38The Epstein–Barr virus and post‐transplant lymphoproliferative disease: interplay of immunosuppression, EBV, and the immune system in disease pathogenesisTransplant Infectious Disease2001114
39Hospitalizations for fungal infections after renal transplantation in the United StatesTransplant Infectious Disease2001114
40Non‐tuberculous mycobacterial infection among lung transplant recipients: a 15‐year cohort studyTransplant Infectious Disease2012114
41Prevention of primary cytomegalovirus disease in organ transplant recipients with oral ganciclovir or oral acyclovir prophylaxisTransplant Infectious Disease2000113
42Polyomavirus-associated nephropathy: update on BK virus-specific immunityTransplant Infectious Disease2006113
43Outcome of influenza infections in outpatients after allogeneic hematopoietic stem cell transplantationTransplant Infectious Disease2009110
44Cytomegalovirus infection and disease in the new era of immunosuppression following solid organ transplantationTransplant Infectious Disease2009109
45Incidence, risk factors, and outcome of bloodstream infections during the pre‐engraftment phase in 521 allogeneic hematopoietic stem cell transplantationsTransplant Infectious Disease2014109
46Variation in antifungal prophylaxis strategies in lung transplantationTransplant Infectious Disease2006108
47A multicenter study of histoplasmosis and blastomycosis after solid organ transplantationTransplant Infectious Disease2012106
48Incidence of histoplasmosis following allogeneic bone marrow transplant or solid organ transplant in a hyperendemic areaTransplant Infectious Disease2002105
49Infectious complications of lung transplantationTransplant Infectious Disease2001104
50Amphotericin B and its new formulations: pharmacologic characteristics, clinical efficacy, and tolerabilityTransplant Infectious Disease1999103